Checkmate Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Checkmate Pharmaceuticals, Inc.
CIK #0001651431
EDGAR Form CIK 2011 - 2024
10-K [0001651431]
10-Q [0001651431]
3 [0001651431]
4 [0001651431]
8-K [0001651431]
D [0001651431]
SC 13D [0001651431]
SC 13G [0001651431]
Form 13D/13G Filer Form 13D/13G Subject Filed
Gardner Lewis Asset Management L P Checkmate Pharmaceuticals Inc [2022-06-03]
Decheng Capital Management III Cayman LLC Checkmate Pharmaceuticals Inc [2022-02-14]
Omega Fund VI LP Checkmate Pharmaceuticals Inc [2021-02-12]
Clough Capital Partners L P Checkmate Pharmaceuticals Inc [2020-11-10]
venBio Global Strategic Fund II LP Checkmate Pharmaceuticals Inc [2020-10-06]
Longitude Capital Partners III LLC Checkmate Pharmaceuticals Inc [2020-08-21]
Sofinnova Venture Partners IX LP Checkmate Pharmaceuticals Inc [2020-08-19]
Medicxi Growth I LP Checkmate Pharmaceuticals Inc [2020-08-18]
Novo Holdings A/S Checkmate Pharmaceuticals Inc [2020-08-13]
Form 3/4/5 Subject 2011 - 2024
Fuhrman Alan
Checkmate Pharmaceuticals, Inc.
Flaherty Keith T.
Isacoff Oren
Colabuono Peter
Yan Joy
Dolski Robert
Wooldridge James
Wigginton Jon Marc
BASH Alan
View All
Terms | Privacy | Guide
tony@aum13f.com